NCT01563744

Brief Summary

Adequate bowel preparation is of critical importance for colonoscopy. Particularly among hospitalized patients, inadequate bowel preparation for colonoscopy may arise due to patient intolerance to prescribed laxative regimen, elderly population, and co-existing conditions that impair the ability to ingest a large-volume laxative regimen. Improvements in bowel preparation for colonoscopy in hospitalized patients would likely improve patient care and reduce hospital costs. The purpose of this study is to determine if administering a portion of the bowel purgative via EGD could improve colonoscopy preparation in hospitalized patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2009

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 27, 2012

Completed
Last Updated

April 19, 2016

Status Verified

April 1, 2012

Enrollment Period

2.6 years

First QC Date

March 23, 2012

Last Update Submit

April 15, 2016

Conditions

Keywords

colonoscopybowel preparationtolerabilityEGD-assisted

Outcome Measures

Primary Outcomes (1)

  • Quality of bowel preparation

    Quality of prep was assessed using the Ottawa bowel preparation scale (Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest endosc 2004;59:482-6)

    Twenty four to 48 hours - from time of consent prior to EGD until end of colonoscopy performed the following day

Secondary Outcomes (1)

  • Patient tolerance of bowel preparation

    administered just prior to sedation for colonoscopy

Study Arms (2)

EGD-assisted colonoscopy prep

EXPERIMENTAL

2 liters of polyethylene glycol instilled through the channel of the endoscope during EGD when colonoscopy expected the following day. Patients follow a clear liquid diet, then ingest an addition 1 liter polyethylene glycol 4 hours prior to colonoscopy. Patients are also given a tap water enema 1 hour prior to colonoscopy.

Procedure: EGD-assisted administration of colonoscopy prep

Standard Colonoscopy Prep

ACTIVE COMPARATOR

Split-dose polyethylene glycol (2 liters pm prior to colonoscopy, 1 liter 4 hours prior to colonoscopy)), clear liquid diet, metoclopramide 10 mg IV 30 minutes prior to procedure, tap water enema 1 hr prior to colonoscopy

Procedure: Control Group received standard prep by oral administration

Interventions

Interventional group receive the first 2 liters of prep solution during EGD through the scope channel if colonoscopy expected the following day.

EGD-assisted colonoscopy prep

Control group receive standard oral colonoscopy prep.

Standard Colonoscopy Prep

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • hospitalized patients
  • having EGD and expected to have colonoscopy the following day
  • written informed consent

You may not qualify if:

  • unable to tolerate EGD-assisted prep administration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

SwedishAmerican Hospital

Rockford, Illinois, 61104, United States

Location

St. Anthony Medical Center

Rockford, Illinois, 61108, United States

Location

Study Officials

  • Robert L. Barclay, MD

    Rockford Gastroenterology Associates, University of Illinois College of Medicine, Rockford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2012

First Posted

March 27, 2012

Study Start

August 1, 2009

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

April 19, 2016

Record last verified: 2012-04

Data Sharing

IPD Sharing
Will not share

Locations